Vertex Pharmaceuticals Incorporated (VRTX)
NASDAQ: VRTX · Real-Time Price · USD
483.96
-10.65 (-2.15%)
Nov 14, 2024, 4:00 PM EST - Market closed

Vertex Pharmaceuticals Operating Expense Breakdown

History

Date Acquired In-Process Research and Development Research and Development Selling, General, and Administrative Change in Value of Contingent Consideration
Jun 30, 20244.60B3.39B1.35B-48.70M
Mar 31, 2024256.80M3.21B1.24B-49.80M
Dec 31, 2023527.10M3.16B1.14B-51.60M
Sep 30, 2023531.90M3.03B1.03B500.00K
Jun 30, 2023509.20M2.87B1.02B-3.30M
Mar 31, 2023460.60M2.68B970.60M-51.90M
Dec 31, 2022115.50M2.54B944.70M-57.50M
Sep 30, 2022221.10M2.41B995.50M-61.30M
Jun 30, 2022218.80M2.23B946.90M-57.50M
Mar 31, 20221.12B2.08B926.20M-6.70M
Dec 31, 20211.11B1.94B840.10M-3.10M
Sep 30, 2021985.10M1.84B733.74M-600.00K
Jun 30, 2021958.40M1.86B720.09M-
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.